- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pelizaeus Merzbacher (PMD)
Total 640 results
-
Fuzhou General HospitalUnknownSmall Cell Lung Cancer | Lung Neoplasm | PD-1 InhibitorsChina
-
West China HospitalRecruitingBRAF V600E-mutated /MSS Metastatic Colorectal Cancer | Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal AntibodyChina
-
Radboud University Medical CenterCompletedParoxysmal Nocturnal Hemoglobinuria | Eculizumab | PK-PDNetherlands
-
AbbVieCompletedParkinson's Disease (PD)United States, Finland, Greece, Hungary, Italy, Slovakia, Spain
-
Tel-Aviv Sourasky Medical CenterUnknownWhite Matter Lesions | Postural Instability Gait DisordersIsrael
-
Nanfang Hospital of Southern Medical UniversityRecruitingEsophageal Squamous Cell Carcinoma | PD-1 InhibitorChina
-
Prism Health North TexasMerck Sharp & Dohme LLCWithdrawnObesity | Metabolic Syndrome | Body Weight Changes | Human Immunodeficiency Virus | Fasting | Minority Health | ART | BMDUnited States
-
Baylor College of MedicineAvex LLCCompletedLymphatic Diseases | Diabetes | Foot Ulcer, Diabetic | PAD | Neuropathy;Peripheral | Lower Extremity EdemaUnited States
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Shanghai Ninth People's Hospital Affiliated to...Not yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Chest HospitalUnknownChemotherapy Effect | KRAS Gene Mutation | NSCLC Stage IV | PD-1 Antibody
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingRecurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
-
Cure CMDCongenital Muscle Disease International RegistrWithdrawnLAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)United States
-
Adamas Pharmaceuticals, Inc.CompletedParkinson's Disease (PD) | Dyskinesia | Levodopa-Induced Dyskinesia (LID)France, Spain, United States, Germany, Austria
-
Beth Israel Deaconess Medical CenterCompletedSialorrheaUnited States
-
Ospedale Generale Di Zona Moriggia-PelasciniUnknownRehabilitation | PD | Gait Dysfunction, NeurologicItaly
-
AstraZenecaRecruitingRecurrent Glioblastoma Multiforme | Brain Neoplasms, Malignant | Primary Glioblastoma Multiforme | Leptomeningeal Disease (LMD)United States, United Kingdom
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityRecruitingNasopharyngeal Carcinoma | Capecitabine | Radiotherapy | PD-1 InhibitorChina
-
Sichuan Cancer Hospital and Research InstituteActive, not recruitingNasopharyngeal Carcinoma | Chemoradiotherapy | PD-1 InhibitorsChina
-
Adamas Pharmaceuticals, Inc.CompletedParkinson's Disease (PD) | Dyskinesia | Levodopa Induced Dyskinesia (LID)France, Spain, United States, Canada, Germany, Austria
-
Shandong New Time Pharmaceutical Co., LTDNot yet recruitingNSCLC | Non-small Cell Lung Cancer | PD-1China
-
Shanghai Jiao Tong University School of MedicineRecruitingOral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFRChina
-
Sun Yat-sen UniversityCompletedBrain Metastases | NSCLC Stage IV | PD-1 AntibodyChina
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Nanfang Hospital of Southern... and other collaboratorsRecruitingNasopharyngeal Carcinoma | Surgery | PD-1China
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
NHS Greater Glasgow and ClydeAbbott Medical Devices; University of GlasgowRecruitingCoronary Artery Disease | Angina, Stable | Microvascular Angina | Vasospastic Angina | Coronary; Ischemic | Non-Obstructive Coronary Atherosclerosis | Ischemia With No Obstructive Coronary Arteries (INOCA) | Coronary Microvascular Dysfunction (CMD) | Ischaemic Heart Disease | Angina AttacksUnited Kingdom
-
Tang-Du HospitalRecruitingChemotherapy | Esophageal Squamous Cell Carcinoma | PD-1 Inhibitor | NeoadjuventChina
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly
-
Guangxi Medical UniversityWuzhou Red Cross Hospital; Wuhan Union Hospital, China; Yunnan Cancer Hospital; Hainan People's Hospital and other collaboratorsNot yet recruitingNasopharyngeal Carcinoma | Neoadjuvant Therapy | PD-1 Inhibitor
-
Tongji HospitalZhejiang Cancer Hospital; Xiangya Hospital of Central South University; Beijing... and other collaboratorsNot yet recruitingCervical Cancer | Locally Advanced Cervical Cancer | PD-L1 Negative | Neoadjuvant ChemoimmunotherapyChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Sun Yat-sen UniversityRecruitingInduction Chemotherapy | Locally Advanced Nasopharyngeal Carcinoma | PD-L1 | EnvafolimabChina
-
CuraSen Therapeutics, Inc.WithdrawnMild Cognitive Impairment (MCI) | Parkinson Disease (PD)
-
RenJi HospitalRecruitingRadiotherapy | Muscle Invasive Bladder Cancer | PD-1 | HER2 Expression | Antibody-drug ConjugatesChina
-
iPACES LLCAlbany Medical College; 1st Playable Productions; Pacific Brain Health Center; Adirondack... and other collaboratorsNot yet recruitingParkinson's Disease | Mild Cognitive Impairment | MCI | PDUnited States
-
Shanghai Jiao Tong University Affiliated Sixth...RecruitingCervical Cancer | Radiotherapy | Neoadjuvant Chemotherapy | PD-1 AntibodyChina
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital & Institute of Guangzhou Medical University and other collaboratorsRecruitingNasopharyngeal Cancer | Chemotherapy | Radiotherapy | PD-1 TherapyChina
-
University of Alabama at BirminghamMassachusetts General HospitalRecruitingCovid19 | Sinusitis | Cystic Fibrosis | COPD | PCD - Primary Ciliary DyskinesiaUnited States
-
W.L.Gore & AssociatesRecruitingEnd-Stage Renal Disease | AAA - Abdominal Aortic Aneurysm | PAD - Peripheral Arterial DiseaseSpain, Italy, France
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownDiabetic Foot | Scleroderma, Systemic | Ischemic Leg | Critical Limb Ischemia | Ischemic Ulcer | Ischemic Feet | Peripheral Arterial Disease - PAD | Thrombo Angiitis ObliteransItaly
-
Bristlecone Health, Inc.University of MinnesotaUnknownDiabetic Macular Edema (DME) | Age-related Macular Degeneration (AMD) | Diabetic Retinopathy (DR) | Mid-peripheral Drusen FormationUnited States
-
Escape Bio, Inc.Momentum Pharma; Science 37TerminatedPatients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) GeneUnited States
-
ACADIA Pharmaceuticals Inc.CompletedTreatment of Depression in Adults With Parkinson's Disease (PD)United States
-
Novartis PharmaceuticalsCompletedVisual Impairment Due to Choroidal Neovascularization (CNV) Secondary to Pathologic Myopia (PM)China, India, Thailand, Hong Kong, Korea, Republic of, Philippines
-
Sun Yat-sen UniversityWuzhou Red Cross Hospital; Fifth Affiliated Hospital, Sun Yat-Sen University; Affiliated Cancer Hospital & Institute of Guangzhou Medical University and other collaboratorsRecruitingNasopharyngeal Carcinoma | Chemotherapy | Radiotherapy | PD-1 TreatmentChina
-
Shirish GadgeelMerck Sharp & Dohme LLCWithdrawnNon Small Cell Lung Cancer | PD-L1 Gene Mutation | Advanced Lung Non-Small Cell Carcinoma
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
Beijing Friendship HospitalNot yet recruitingLymphoma | Hemophagocytic Lymphohistiocytosis | PD-1 Antibody | Epstein-Barr VirusChina
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingProgressive Disease | Mesothelioma, Malignant | Advanced Cancer | PD-L1 NegativeItaly